pCDNA3.1- dCas9-2xNLS-EGFP Citations (4)

Originally described in: Programmable RNA Tracking in Live Cells with CRISPR/Cas9.
Nelles DA, Fang MY, O'Connell MR, Xu JL, Markmiller SJ, Doudna JA, Yeo GW Cell. 2016 Mar 16. pii: S0092-8674(16)30204-5. doi: 10.1016/j.cell.2016.02.054. PubMed Journal

---

Articles Citing pCDNA3.1- dCas9-2xNLS-EGFP

Articles
Visualization of Xist Long Noncoding RNA with a Fluorescent CRISPR/Cas9 System. Wasko U, Zheng Z, Bhatnagar S. Methods Mol Biol. 2019;1870:41-50. doi: 10.1007/978-1-4939-8808-2_3. PubMed
Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy. Rong Z, Gong X, Hulleman JD, Corey DR, Mootha VV. Transl Vis Sci Technol. 2020 Aug 31;9(9):47. doi: 10.1167/tvst.9.9.47. eCollection 2020 Aug. PubMed
Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing. Marina RJ, Brannan KW, Dong KD, Yee BA, Yeo GW. Cell Rep. 2020 Nov 3;33(5):108350. doi: 10.1016/j.celrep.2020.108350. PubMed
Nuclear lamina strain states revealed by intermolecular force biosensor. Danielsson BE, George Abraham B, Mantyla E, Cabe JI, Mayer CR, Rekonen A, Ek F, Conway DE, Ihalainen TO. Nat Commun. 2023 Jun 30;14(1):3867. doi: 10.1038/s41467-023-39563-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.